Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating DWP14012 for non-erosive gastroesophageal reflux disease (NERD) is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Esophageal Reflux Disease
• Non-erosive Gastro-esophageal Reflux Disease
• Non-erosive Reflux Disease

Drugs mentioned

• DWP14012

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Non-erosive Reflux Disease, Non-Erosive Gastro-Esophageal Reflux Disease | Phase 3 | Status: UNKNOWN